|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | [[Image:Small-cell-lung-cancer.jpg|400px|left|thumb| CT of SCLC showing extensive stage-Venous phase]] |
| {{Waldenström's macroglobulinemia}}
| |
| {{CMG}}{{AE}} {{MGS}}
| |
| | |
| {| style="border: 0px; font-size: 90%; margin: 3px; width: 800px"
| |
| |valign=top|
| |
| |+
| |
| ! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Treatment Regimen}}
| |
| ! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Drugs}}
| |
| ! style="background: #4479BA; width: 300px;" | {{fontcolor|#FFF|Side effects}}
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| |
| '''CHOP-R regimen'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Cyclophosphamide
| |
| *Doxorubicin
| |
| *Vincristine
| |
| *Prednisone
| |
| *Rituximab
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Nausea
| |
| *Alopecia
| |
| *Granulocytopenia
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| |
| '''Ibrutinib'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Ibrutinib
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Fatigue
| |
| *Cytopenia
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| |
| '''Rituximab'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Rituximab
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Infusion related reaction
| |
| *Infections
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| |
| '''FR regimen'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Fludarabine
| |
| *Rituximab
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Neutropenia (63%)
| |
| *Thrombocytopenia
| |
| *Pneumonia
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| |
| '''BDR regimen'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | | |
| *Bortezomib
| |
| *Dexamethasone
| |
| *Rituximab
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | | |
| *Peripheral Neuropathy - reversible in 61% of patients
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| |
| '''DRC regimen'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Dexamethasone
| |
| *Rituximab
| |
| *Cyclophosphamide
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Neutropenia
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| |
| '''CR regimen'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Cladribine
| |
| *Rituximab
| |
| | style="padding: 5px 5px; background: #F5F5F5;" |
| |
| *Anemia
| |
| *Neurological symptoms
| |
| *Symptomatic cryoglobulinemia
| |
| *Thrombocytopenia
| |
| |-
| |
| |}
| |
| | |
| | |
| | |
| ==References==
| |
| {{reflist|2}}
| |
| | |
| {{WH}}
| |
| {{WS}}
| |
| | |
| | |
| [[Category:Disease]]
| |
| [[Category:Blood]]
| |
| [[Category:Hematology]]
| |
